News
US drug tariffs may not hit branded prices hard, but generics and supply chains face disruption. Here's what pharma leaders ...
Discover a study that ssessed the potential of urinary biomarkers to predict patient mortality in cirrhotic individuals.
AN OPEN-SOURCE AI tool developed by University of Florida researchers, VisionMD, significantly improves the monitoring of ...
New data from a 10-year review reveal key trends in pediatric medical tourism, with children traveling to the U.S. for cancer and hematologic treatments—primarily from upper-middle-income countries.
A digitally controlled, AI-assisted ICSI system has successfully produced a live birth, marking a major milestone in ...
A school-based asthma therapy program in Columbus, Ohio led to sharp reductions in ER visits, hospitalizations, and intensive ...
A comprehensive global study highlights rising female cancer rates and the impact of socioeconomic factors, revealing stark ...
As Chair, my main responsibilities include shaping the thematic structure and plenary sessions of the EAU Congress 2025, ...
A new 96-week study confirms the long-term safety and sustained efficacy of elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis aged 6–11 years.
A new study reveals that fermented cabbage metabolites help shield intestinal cells from inflammation-induced barrier ...
Discover a recent study that indicates that autonomous total body photography could be a valuable tool in dermatological settings.
New findings from the HERO Study show a 96% cure rate in hepatitis C retreatment among people who inject drugs. See what this means for HCV elimination goals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results